bg
I

Inmune Bio (INMB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Inmune Bio (INMB)

INmune Bio Inc. operates as a clinical stage biotechnology company. The Company develops medicines to treat cancer. INmune Bio serves clients in the United States.

  • USD7.77
  • USD7.77
  • USD6.85
  • USD11.47
  • 3.70%
  • 0M
  • 238.24k
  • 217.53k
  • 178M
  • 4.32
  • -32.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.